Duration, dose, and responsiveness to erythropoiesis-stimulating agents and risk of osteoporotic fracture among patients with chronic kidney disease in Hong Kong: a nested case–control study

ABSTRACT:

SUBMITTER: Ho S 

PROVIDER: S-EPMC12766426 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature